1. Home
  2. ERAS vs FRBA Comparison

ERAS vs FRBA Comparison

Compare ERAS & FRBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERAS
  • FRBA
  • Stock Information
  • Founded
  • ERAS 2018
  • FRBA 2007
  • Country
  • ERAS United States
  • FRBA United States
  • Employees
  • ERAS N/A
  • FRBA N/A
  • Industry
  • ERAS Biotechnology: Pharmaceutical Preparations
  • FRBA Major Banks
  • Sector
  • ERAS Health Care
  • FRBA Finance
  • Exchange
  • ERAS Nasdaq
  • FRBA Nasdaq
  • Market Cap
  • ERAS 439.7M
  • FRBA 364.6M
  • IPO Year
  • ERAS 2021
  • FRBA N/A
  • Fundamental
  • Price
  • ERAS $1.71
  • FRBA $16.40
  • Analyst Decision
  • ERAS Buy
  • FRBA Strong Buy
  • Analyst Count
  • ERAS 6
  • FRBA 2
  • Target Price
  • ERAS $3.83
  • FRBA $18.00
  • AVG Volume (30 Days)
  • ERAS 964.1K
  • FRBA 45.6K
  • Earning Date
  • ERAS 11-11-2025
  • FRBA 10-22-2025
  • Dividend Yield
  • ERAS N/A
  • FRBA 1.46%
  • EPS Growth
  • ERAS N/A
  • FRBA 23.16
  • EPS
  • ERAS N/A
  • FRBA 1.51
  • Revenue
  • ERAS N/A
  • FRBA $131,202,000.00
  • Revenue This Year
  • ERAS N/A
  • FRBA $12.28
  • Revenue Next Year
  • ERAS N/A
  • FRBA $6.37
  • P/E Ratio
  • ERAS N/A
  • FRBA $10.86
  • Revenue Growth
  • ERAS N/A
  • FRBA 14.51
  • 52 Week Low
  • ERAS $1.01
  • FRBA $12.74
  • 52 Week High
  • ERAS $3.31
  • FRBA $17.40
  • Technical
  • Relative Strength Index (RSI)
  • ERAS 59.36
  • FRBA 50.84
  • Support Level
  • ERAS $1.53
  • FRBA $16.60
  • Resistance Level
  • ERAS $1.69
  • FRBA $17.40
  • Average True Range (ATR)
  • ERAS 0.10
  • FRBA 0.29
  • MACD
  • ERAS 0.01
  • FRBA -0.07
  • Stochastic Oscillator
  • ERAS 96.20
  • FRBA 8.26

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.

About FRBA First Bank

First Bank is a full-service commercial bank, with target businesses from individuals, businesses, and governmental entities located in service regions throughout New Jersey and eastern Pennsylvania, with a particular focus between New York City and Philadelphia. The group focuses on traditional deposit and loan products with businesses and individuals living and working in markets as the source of businesses. Its services are Business Banking; Personal banking; Digital Banking; and Lending.

Share on Social Networks: